医护人员接种第二剂阿斯利康新冠疫苗后不良反应的性别差异:一项横断面研究
该横断面研究纳入伊朗西部克尔曼沙赫市两所教学医院的780名医护人员,调查其接种第二剂阿斯利康新冠疫苗后一个月内不良反应的性别差异。女性总体不良反应比例较高但未达统计学显著(OR=1.83,p=0.056);调整逻辑回归显示女性寒战、恶心、胃肠道症状、流涕、发热、身体疼痛和疲劳的 odds 显著高于男性。结论认为女性不良反应发生率更高,提示性别因素影响疫苗反应。
要点
- 女性第二剂阿斯利康疫苗后总体不良反应比例较高但未显著(OR=1.83,p=0.056)。
- 女性寒战(OR=2.17)、恶心(OR=2.98)、胃肠道症状(OR=2.1)、发热(OR=1.64)、疲劳(OR=1.85)等 odds 显著高于男性。
- 发热的归因风险性别差距最大,为15%。
核心结论
- 女性接种第二剂阿斯利康新冠疫苗后不良反应发生率较高,提示性别因素影响疫苗反应。
- 作者认为有必要对女性进行进一步检查,以降低注射操作引起并发症的风险。
研究设计与样本
- 横断面研究,纳入780名在伊朗西部克尔曼沙赫市两所教学医院工作并已接种第二剂阿斯利康疫苗的医护人员。
- 不良反应调查时间为接种第二剂阿斯利康疫苗后最长一个月。
主要发现
- 第二剂阿斯利康新冠疫苗后总体不良反应比例女性高于男性,但未达统计学显著(OR=1.83,p=0.056)。
- 调整逻辑回归显示女性寒战 odds 显著高于男性(OR=2.17,p=0.001)。
- 女性恶心 odds 显著高于男性(OR=2.98,p=0.012)。
- 女性胃肠道症状 odds 显著高于男性(OR=2.1,p=0.001)。
- 女性流涕(OR=1.5,p=0.047)、发热(OR=1.64,p=0.002)、身体疼痛(OR=1.4,p=0.04)、疲劳(OR=1.85,p=0.001)的 odds 均显著高于男性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaccination in pandemic diseases, in addition to positive effects on controlling the prevalence and reducing the resulting socioeconomic effects, can have adverse effects with different intensity based on gender, type and dose of vaccine. We aimed to investigate gender differences in adverse effects following the second dose of AstraZeneca Covid-19 vaccine among healthcare workers (HWs). METHOD: This cross-sectional study was conducted on 780 HWs who worked in two educational hospitals in Kermanshah city, western Iran, and had received the second dose of AstraZeneca vaccine. The duration of the investigation of the adverse effects was a maximum of one month after receiving the second dose of AstraZeneca vaccine. RESULTS: The overall proportion of adverse effects following the second dose of the AstraZeneca Covid-19 vaccine was higher in female participants, but it was not significant (OR=1.83, p=0.056). The results of adjusted logistic regression showed that the odds of chills (OR=2.17, p=0.001), nausea (OR=2.98, p=0.012), and gastrointestinal symptoms (OR=2.1, p=0.001), runny nose (OR=1.5, p=0.047), fever (OR=1.64, p=0.002), body pain (OR=1.4, p=0.04), and fatigue (OR=1.85, p=0.001) were significantly higher in females than in males. The maximum gap of 15% (attributable risk) was shown for fever adverse between genders. CONCLUSION: The higher occurrence rate of side effects after second dose of AstraZeneca Covid-19 vaccine in women, indicates that gender factors influence the response to the vaccine, consequently, it is imperative that women undergo further examination to mitigate the risk of complications arising from injection procedures.
引用
- Sedaghat M, Karami B, Najafi F, et al. Gender differences in adverse effects following the second dose of AstraZeneca COVID-19 vaccine: a cross-sectional study among healthcare workers. Vaccine. 2024. PMID: 39413489. doi:10.1016/j.vaccine.2024.126424
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。